A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Neurosciences Bookmark and Share

Neurosciences

Study of the nervous system has a long tradition at City of Hope, which was one of the first institutions in North America to establish a neurobiology research department.

The Department of Neurosciences offers a multidisciplinary research and training environment in neurobiology, with a particular focus on developmental aspects of the nervous system. Research in the department encompasses molecular and cellular neurobiology, genetics and neurophysiology, with ongoing studies in neurogenesis and synaptogenesis, migration and specification, degeneration and embryonic stem cell differentiation.

Researchers in the department collaborate with colleagues in other basic science departments and divisions as well as clinical researchers in neuro-oncology programs, focusing on cancer immunotherapy and neurosurgery.
 
Laboratory Research
The Department of Neurosciences spans a broad range of research interests; grouped into three major categories:

I.Several investigators are interested in the earliest periods of neurogenesis and lineage commitment, and are examining stem and progenitor cells in developing and mature brain:
 
  • Qiang Lu, Ph.D. – Neural Progenitor/Stem Cells in Brain Development
    Dr. Lu’s research is concerned with intercellular signaling by ephrins and Eph receptors and their regulation of neuronal birth and migration during early development of the cerebral cortex.
 
  • Yanhong Shi, Ph.D. – Nuclear Receptors in Neural Stem Cells and Adult Neurogenesis
    Dr. Shi is studying the nuclear receptors that control generation and differentiation of neural lineage stem cells in the adult nervous system.
 
  • Michael Barish, Ph.D. – Neurobiology of Development
    Dr. Barish is investigating early electrical activity in the developing hippocampus and cortex and its relationship to neural birth, migration and maturation.
     
  • Karen S. Aboody, M.D.Translational Research
    Dr. Aboody oversees a translational research laboratory focused on neural stem cells (NSCs) as a platform for targeted delivery of therapeutic agents to invasive and metastatic solid tumors.

II.Several faculty have research foci in neural specification, processes that impart individuality to developing neurons, and in the functioning of mature neurons.
 
  • Paul Salvaterra, Ph.D. – Molecular Neurobiology
    Dr. Salvaterra’s research is focused on the regulation of transmitter phenotype, how gene expression is coordinated to allow synthesis and release of individual neurotransmitters.
 
  • Toshifumi Tomoda, Ph.D. – Axonal Trafficking / Neurodegeneration
    Dr. Tomoda is interested in membrane transport and cycling, and its role in axon and dendrite growth, differentiation of synapses, and stress-induced autophagy.
 
  • Kazuo Ikeda, Ph.D. – Neurophysiology
    Dr. Ikeda studies the mechanisms of synaptic transmission and plasticity, focusing on endocytosis of synaptic vesicle membrane from presynaptic terminals and processes of recovery from vesicle depletion as a consequence of activity.

III.Several faculty members also have projects that relate their fundamental research interests to mechanisms underlying diseases of the human nervous system.
 
  • Dr. Salvaterra is developing Drosophila models for Alzheimer’s and other degenerative diseases.
     
  • Dr. Lu is examining how alteration in the neural stem cell decision to proliferate or differentiate controlled by ephrin/Eph receptor signaling may be involved in the earliest stages of tumorigenesis.
     
  • Dr. Tomoda is investigating possible connections between genes involved in membrane cycling and autophagy, and several diseases including Huntington’s and schizophrenia.
     
  • Dr. Barish, in collaboration with Karen Aboody, M.D. , (Hematology/HCT) and Carlotta Glackin, Ph.D. , is examining the molecular mechanisms of neural progenitor cell migration to glioma and tumors outside the brain, and targeting of these tumors with genetically-modified therapeutics using immortalized neural progenitor cells.
     
  • Dr. Glackin and her laboratory are investigating the molecular mechanisms of a bHLH transcription factor, TWIST, in regulating cellular invasiveness. Understanding these mechanisms has allowed her laboratory to develop novel genetically-modified therapeutics that interferes with TWIST function to competitively inhibit cellular invasion of tumor cells.

Neurosciences Faculty

Neurosciences

Neurosciences

Study of the nervous system has a long tradition at City of Hope, which was one of the first institutions in North America to establish a neurobiology research department.

The Department of Neurosciences offers a multidisciplinary research and training environment in neurobiology, with a particular focus on developmental aspects of the nervous system. Research in the department encompasses molecular and cellular neurobiology, genetics and neurophysiology, with ongoing studies in neurogenesis and synaptogenesis, migration and specification, degeneration and embryonic stem cell differentiation.

Researchers in the department collaborate with colleagues in other basic science departments and divisions as well as clinical researchers in neuro-oncology programs, focusing on cancer immunotherapy and neurosurgery.
 
Laboratory Research
The Department of Neurosciences spans a broad range of research interests; grouped into three major categories:

I.Several investigators are interested in the earliest periods of neurogenesis and lineage commitment, and are examining stem and progenitor cells in developing and mature brain:
 
  • Qiang Lu, Ph.D. – Neural Progenitor/Stem Cells in Brain Development
    Dr. Lu’s research is concerned with intercellular signaling by ephrins and Eph receptors and their regulation of neuronal birth and migration during early development of the cerebral cortex.
 
  • Yanhong Shi, Ph.D. – Nuclear Receptors in Neural Stem Cells and Adult Neurogenesis
    Dr. Shi is studying the nuclear receptors that control generation and differentiation of neural lineage stem cells in the adult nervous system.
 
  • Michael Barish, Ph.D. – Neurobiology of Development
    Dr. Barish is investigating early electrical activity in the developing hippocampus and cortex and its relationship to neural birth, migration and maturation.
     
  • Karen S. Aboody, M.D.Translational Research
    Dr. Aboody oversees a translational research laboratory focused on neural stem cells (NSCs) as a platform for targeted delivery of therapeutic agents to invasive and metastatic solid tumors.

II.Several faculty have research foci in neural specification, processes that impart individuality to developing neurons, and in the functioning of mature neurons.
 
  • Paul Salvaterra, Ph.D. – Molecular Neurobiology
    Dr. Salvaterra’s research is focused on the regulation of transmitter phenotype, how gene expression is coordinated to allow synthesis and release of individual neurotransmitters.
 
  • Toshifumi Tomoda, Ph.D. – Axonal Trafficking / Neurodegeneration
    Dr. Tomoda is interested in membrane transport and cycling, and its role in axon and dendrite growth, differentiation of synapses, and stress-induced autophagy.
 
  • Kazuo Ikeda, Ph.D. – Neurophysiology
    Dr. Ikeda studies the mechanisms of synaptic transmission and plasticity, focusing on endocytosis of synaptic vesicle membrane from presynaptic terminals and processes of recovery from vesicle depletion as a consequence of activity.

III.Several faculty members also have projects that relate their fundamental research interests to mechanisms underlying diseases of the human nervous system.
 
  • Dr. Salvaterra is developing Drosophila models for Alzheimer’s and other degenerative diseases.
     
  • Dr. Lu is examining how alteration in the neural stem cell decision to proliferate or differentiate controlled by ephrin/Eph receptor signaling may be involved in the earliest stages of tumorigenesis.
     
  • Dr. Tomoda is investigating possible connections between genes involved in membrane cycling and autophagy, and several diseases including Huntington’s and schizophrenia.
     
  • Dr. Barish, in collaboration with Karen Aboody, M.D. , (Hematology/HCT) and Carlotta Glackin, Ph.D. , is examining the molecular mechanisms of neural progenitor cell migration to glioma and tumors outside the brain, and targeting of these tumors with genetically-modified therapeutics using immortalized neural progenitor cells.
     
  • Dr. Glackin and her laboratory are investigating the molecular mechanisms of a bHLH transcription factor, TWIST, in regulating cellular invasiveness. Understanding these mechanisms has allowed her laboratory to develop novel genetically-modified therapeutics that interferes with TWIST function to competitively inhibit cellular invasion of tumor cells.

Neurosciences Faculty

Neurosciences Faculty

Overview
Beckman Research Institute of City of Hope is responsible for fundamentally expanding the world’s understanding of how biology affects diseases such as cancer, HIV/AIDS and diabetes.
 
 
Research Departments/Divisions

City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.
 

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 


NEWS & UPDATES
  • Urinary tract stones are hard masses, or calculi, that form in the urinary tract and may cause pain, bleeding or an infection, or even block of the flow of urine. Urinary tract stones begin to form in a kidney and may enlarge in a ureter or the bladder. Depending on where a stone is located, […]
  • Every summer, hospitals nationwide experience a shortage of blood donations. This summer is no exception. Nearly 1.7 million new cancer cases are expected to be diagnosed in the U.S. this year,  and many of those patients will need blood transfusions during their treatment. Patients at City of Hope alone rely o...
  • Non-Hodgkin lymphoma facts: Non-Hodgkin lymphoma is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Lymphocytes are in the lymph nodes and other lymphoid tissues (such as the spleen and bone marrow). Non-Hodgkin lymphoma is one of the most common cancers in the U.S....
  • Few clinical cancer trials include older adults – and yet, more than 60 percent of cancer cases in the United States occur in people age 65 and older. The result is a dearth of knowledge on how to treat the very population most likely to be diagnosed with cancer. Now, the American Society of Clinical […]
  • Scientists at City of Hope and UCLA have become the first to inhibit the expression of a protein, called TWIST that promotes tumor invasion and metastasis when activated by cancer cells. As such, they’ve taken the first step in developing a potential new therapy for some of the deadliest cancers, including ovar...
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...
  • Women diagnosed with breast cancer quickly learn their tumor’s type, meaning the characteristics that fuel its growth. That label guides the treatment of their disease, as well as their prognosis when it comes to treatment effectiveness. Sometimes, however, doctors can’t accurately predict treatment effectivene...